In today’s recent session, 5.42 million shares of the Vallon Pharmaceuticals Inc. (NASDAQ:VLON) were traded. Most recently the company’s share price was $0.45, and it changed around $0.06 or 16.01% from the last close, which brings the market valuation of the company to $4.36M. VLON at last check was trading at a discount to its 52-week high of $10.36, offering almost -2202.22% off that amount. The share price’s 52-week low was $0.34, which indicates that the recent value has risen by an impressive 24.44% since then. We note from Vallon Pharmaceuticals Inc.’s average daily trading volume that its 10-day average is 0.16 million shares, with the 3-month average coming to 357.80K.
Vallon Pharmaceuticals Inc. stock received a consensus recommendation rating of a Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended VLON as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Vallon Pharmaceuticals Inc. is expected to report earnings per share of $0 for the current quarter.
Vallon Pharmaceuticals Inc. (NASDAQ:VLON) trade information
Instantly VLON has been showing a green trend so far today with a performance of 16.01% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6960 on Tuesday, 08/02/22 increased the stock’s daily price by 35.34%. The company’s shares are currently down -93.51% year-to-date, but still down -17.45% over the last five days. On the other hand, Vallon Pharmaceuticals Inc. (NASDAQ:VLON) is -37.44% down in the 30-day period. We can see from the shorts that 0.14 million shares have been sold at a short interest cover period of 0.31 day(s).
The consensus price target as assigned by Wall Street analysts is $12.00, which translates to bulls needing to increase their stock price by 96.25% from its current value. Analyst projections state that VLON is forecast to be at a low of $12.00 and a high of $12.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2566.67% from its current level, while the stock would need to crash -2566.67% from its current level to reach the projected low.
Vallon Pharmaceuticals Inc. (VLON) estimates and forecasts
Vallon Pharmaceuticals Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -92.05 percent over the past six months and at a 30.28% annual growth rate that is well above the industry average of 1.00%.
Vallon Pharmaceuticals Inc.’s next quarterly earnings report is expected to be released around March 28 and April 01.
Vallon Pharmaceuticals Inc. (NASDAQ:VLON)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 46.97% of Vallon Pharmaceuticals Inc. shares, and 23.22% of them are in the hands of institutional investors. The stock currently has a share float of 43.79%. Vallon Pharmaceuticals Inc. stock is held by 19 institutions, with Ikarian Capital, LLC being the largest institutional investor. By Mar 30, 2022, it held 1.92% of the shares, which is about 0.2 million shares worth $0.38 million.
Vanguard Group, Inc. (The), with 0.97% or 0.1 million shares worth $0.19 million as of Mar 30, 2022, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 30, 2022. The former held 78200.0 shares worth $0.15 million, making up 0.74% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 22146.0 shares worth around $41634.0, which represents about 0.21% of the total shares outstanding.